Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...

Isomorphic Labs is the secretive AI life sciences startup spun out of Google DeepMind with the goal of solving all disease ...

The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...

Alphabet spinoff SandboxAQ — an AI and quantum computing startup — added another $150 million to its Series E from the likes ...

Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which ...

While Isomorphic is an independent unit of Google parent Alphabet, Hassabis' dual roles reflect the intertwined relationship between the two parties. Isomorphic has never revealed how much Google ...